First Tracks Biotherapeutics Ordinary Shares When-Issued Insider Trades

TRAXV

Track insider trading activity from First Tracks Biotherapeutics Ordinary Shares When-Issued executives and directors. See which insiders are buying and selling TRAXV stock.

Trades Last 12 Months

TRAXV Price

All Insider Trades for First Tracks Biotherapeutics Ordinary Shares When-Issued

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Orwin John A Director
Holding Value $405k 17,995 shares
Last Trade
Sep 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$29.3k 1,300 shares
$22.51
$22.51
Ware J. Anthony Director
Holding Value $0 0 shares
Last Trade
Sep 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$884k 39,265 shares
$22.51
$22.51
Faga Daniel President, CEO
Holding Value $9.92M 440,485 shares
Last Trade
Aug 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.36M 193,575 shares
$22.51
$22.51
Lizzul Paul F. Chief Medical Officer
Holding Value $3.1M 137,651 shares
Last Trade
Aug 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.36M 60,492 shares
$22.51
$22.51
Stone Benjamin Chief Business Officer
Holding Value $3.1M 137,651 shares
Last Trade
Aug 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.36M 60,492 shares
$22.51
$22.51
Anaptysbio, Inc 10% owner
Holding Value $0 0 shares
Last Trade
Apr 20, 2026 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$2.25k 100 shares
$22.51
$22.51

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up